Company Data
Rallybio Corporation
Ticker
RLYB
Current Price
$0.7345 -2.52%
Market Cap
$30.5M
Price Target
Refer to Report
Volume
103.0K
52wk Range
$0.725 - $3.46
Overview
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.